Jianfeng Wang

1 ta ish

National Institutes for Food and Drug Control

1. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials

   Shilong Yang, Yan Li, Lianpan Dai +26

   MaqolaOAOchiq kirish20216 iqtibos

   ABIABI:AkademIndex/2026.other.232420